CN105578903B - 用于控制糖尿病或前驱糖尿病的组合物和方法 - Google Patents

用于控制糖尿病或前驱糖尿病的组合物和方法 Download PDF

Info

Publication number
CN105578903B
CN105578903B CN201380038152.4A CN201380038152A CN105578903B CN 105578903 B CN105578903 B CN 105578903B CN 201380038152 A CN201380038152 A CN 201380038152A CN 105578903 B CN105578903 B CN 105578903B
Authority
CN
China
Prior art keywords
beverage
serving
water
protein
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380038152.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN105578903A (zh
Inventor
克里斯托弗·沃尔特·利希蒂
彼得·理查德·温特·贝斯特
简娜·弗朗西斯·贝斯特
戈特弗里德·利希蒂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omniblend Innovation Pty Ltd
Original Assignee
Omniblend Innovation Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012904029A external-priority patent/AU2012904029A0/en
Application filed by Omniblend Innovation Pty Ltd filed Critical Omniblend Innovation Pty Ltd
Publication of CN105578903A publication Critical patent/CN105578903A/zh
Application granted granted Critical
Publication of CN105578903B publication Critical patent/CN105578903B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1412—Containers with closing means, e.g. caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
    • B65D25/54—Inspection openings or windows
    • B65D25/56—Inspection openings or windows with means for indicating level of contents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/50—Polysaccharides, gums
    • A23V2250/502—Gums
    • A23V2250/5074—Psyllium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/542—Animal Protein
    • A23V2250/5424—Dairy protein
    • A23V2250/54252—Whey protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mechanical Engineering (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
CN201380038152.4A 2012-05-23 2013-05-22 用于控制糖尿病或前驱糖尿病的组合物和方法 Active CN105578903B (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261650769P 2012-05-23 2012-05-23
US61/650,769 2012-05-23
AU2012904029 2012-09-14
AU2012904029A AU2012904029A0 (en) 2012-09-14 Composition and method for management of diabetes or pre-diabetes
AU2013204801A AU2013204801B2 (en) 2012-05-23 2013-04-12 Composition and method for management of diabetes or pre-diabetes
AU2013204801 2013-04-12
PCT/AU2013/000537 WO2013173874A2 (en) 2012-05-23 2013-05-22 Composition and method for management of diabetes or pre-diabetes

Publications (2)

Publication Number Publication Date
CN105578903A CN105578903A (zh) 2016-05-11
CN105578903B true CN105578903B (zh) 2018-08-07

Family

ID=49624403

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380038152.4A Active CN105578903B (zh) 2012-05-23 2013-05-22 用于控制糖尿病或前驱糖尿病的组合物和方法

Country Status (11)

Country Link
US (2) US9675553B2 (https=)
EP (1) EP2852298B1 (https=)
JP (1) JP6414897B2 (https=)
KR (1) KR102115863B1 (https=)
CN (1) CN105578903B (https=)
AU (1) AU2013204801B2 (https=)
CA (1) CA2874034C (https=)
IL (1) IL235855A (https=)
NZ (1) NZ701302A (https=)
WO (1) WO2013173874A2 (https=)
ZA (1) ZA201408480B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1223034A1 (zh) * 2013-11-19 2017-07-21 Omniblend Innovation Pty Ltd 用於治疗2型糖尿病的方法和养生方案
US20180139987A1 (en) * 2015-04-23 2018-05-24 Omniblend Innovation Pty Ltd Pharmaceutical powder composition and its use in the control of post-prandial glycaemic profile
AU2021305336B2 (en) * 2020-07-10 2025-02-06 C° Change Surgical Llc Injectable slush feed supply

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191102A (en) * 1978-07-25 1982-03-09 Wellcome Found Pharmaceutical formulations of galactomannan
CA1201321A (en) 1981-12-22 1986-03-04 Anne-Marie Dahlen Protein-fruit drink
CA1221575A (en) 1983-10-17 1987-05-12 John A. Colliopoulos Psyllium mucilloid products
US4921877A (en) 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US5104676A (en) 1991-06-27 1992-04-14 Abbott Laboratories Weight control product
US5547275A (en) * 1995-08-17 1996-08-20 Dart Industries Inc. Shaker and blender
US5747532A (en) 1995-11-21 1998-05-05 Medinox, Inc. Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
US6139900A (en) * 1998-08-11 2000-10-31 North Carolina State University Method of forming whey protein products
GB9927603D0 (en) 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
US6365176B1 (en) 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
GB0213612D0 (en) 2002-06-13 2002-07-24 Novartis Nutrition Ag Organic compounds
US20040087514A1 (en) * 2002-09-06 2004-05-06 Hughes Thomas E Nutritional compositions
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
CA2507764A1 (en) 2002-12-20 2004-07-08 Unilever Plc Blood glucose regulating composition
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
US7824706B2 (en) * 2003-05-09 2010-11-02 Freedom Health, Llc Dietary supplement and method for the treatment of digestive tract ulcers in equines
BRPI0412189A (pt) 2003-06-30 2006-08-22 Nestec Sa composição para tratar e/ou prevenir disfunções associadas à diabetes melito do tipo 2
JP2005204943A (ja) * 2004-01-22 2005-08-04 Shusuke Nagai カクテルシェーカー
GB2432772B (en) * 2005-11-30 2011-06-01 Sis Improvements in and relating to nutritional products
PL1983849T3 (pl) 2006-01-20 2013-09-30 Innova Food Ab Kompozycja spożywcza zawierająca aminokwasy
US7977319B1 (en) 2006-04-03 2011-07-12 Scott David Levine Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins
EP2003991A1 (en) 2006-04-12 2008-12-24 DSM IP Assets B.V. Novel nutraceutical compositions
US8518469B2 (en) 2007-06-12 2013-08-27 Kraft Foods Group Brands Llc Powdered beverage composition
AU2009222965B2 (en) 2008-03-13 2014-10-02 Immuron Limited Immuno-modulating compositions for the treatment of immune-mediated disorders
CA2676518A1 (en) 2008-08-29 2010-02-28 Kraft Foods Global Brands Llc Whey protein pre-load
EA024697B1 (ru) 2009-04-27 2016-10-31 Иммурон Лимитед Применение композиции, содержащей обогащенный анти-lps-антителами иммуноглобулиновый препарат, для лечения заболеваний печени
EP2512460A4 (en) * 2009-12-18 2015-01-21 Exodos Life Sciences Ltd Partnership METHOD AND COMPOSITIONS FOR STABLE LIQUID ACTIVE FORMULATIONS

Also Published As

Publication number Publication date
AU2013204801B2 (en) 2014-11-06
EP2852298A4 (en) 2016-07-06
CN105578903A (zh) 2016-05-11
ZA201408480B (en) 2015-12-23
IL235855A (en) 2017-09-28
US20170189332A1 (en) 2017-07-06
IL235855A0 (en) 2015-01-29
HK1208783A1 (en) 2016-03-18
JP6414897B2 (ja) 2018-10-31
WO2013173874A3 (en) 2015-06-11
US20150164793A1 (en) 2015-06-18
EP2852298A2 (en) 2015-04-01
WO2013173874A2 (en) 2013-11-28
NZ701302A (en) 2017-07-28
CA2874034A1 (en) 2013-11-28
EP2852298B1 (en) 2018-11-14
KR20150013792A (ko) 2015-02-05
CA2874034C (en) 2021-05-25
US9675553B2 (en) 2017-06-13
US9775801B2 (en) 2017-10-03
KR102115863B1 (ko) 2020-05-28
JP2015533076A (ja) 2015-11-19

Similar Documents

Publication Publication Date Title
BR112014008692B1 (pt) Medicamento fluível ou ingerível por colher, alimento, ingrediente alimentício ou suplemento alimentar
CN105578903B (zh) 用于控制糖尿病或前驱糖尿病的组合物和方法
CN114258269A (zh) 用以促进患有吞咽困难的个体安全吞咽的增稠剂和营养产品以及它们的制备和使用方法
TW201334774A (zh) 使用β－羥基－β－甲基丁酸鹽與精胺酸及麩醯胺酸促進糖尿病性潰瘍康復的方法
AU2014353872B2 (en) Composition and method for control of post-prandial glucose
CN117355222A (zh) 促进吞咽困难个体安全吞咽的稳定增稠剂和营养产品及其制备和使用方法
HK1208783B (en) Composition for management of diabetes or pre-diabetes
US20160287515A1 (en) Regimen and method for treatment of type 2 diabetes
HK1222993B (en) Composition and method for control of post-prandial glucose
US20180139987A1 (en) Pharmaceutical powder composition and its use in the control of post-prandial glycaemic profile
HK40072182A (en) Thickeners and nutritional products to promote safe swallowing for individuals with dysphagia and methods of making and using same
NZ720647B2 (en) Composition and method for control of post-prandial glucose
TW200533300A (en) Composition for inhibting dietary lipid absorption

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant